KINGSEMI Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

KINGSEMI heeft een totaal eigen vermogen van CN¥2.5B en een totale schuld van CN¥1.2B, wat de schuld-eigenvermogensverhouding op 46.9% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥5.0B en CN¥2.5B. De EBIT KINGSEMI is CN¥108.0M waardoor de rentedekking 11.2 is. Het heeft contanten en kortetermijnbeleggingen van CN¥1.2B.

Belangrijke informatie

46.9%

Verhouding schuld/eigen vermogen

CN¥1.19b

Schuld

Rente dekkingsratio	11.2x
Contant	CN¥1.16b
Aandelen	CN¥2.53b
Totaal verplichtingen	CN¥2.49b
Totaal activa	CN¥5.02b

Recente financiële gezondheidsupdates

KINGSEMI (SHSE:688037) Has A Somewhat Strained Balance Sheet

Jul 26

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

Mar 19

Recent updates

Earnings Tell The Story For KINGSEMI Co., Ltd. (SHSE:688037) As Its Stock Soars 27%

Jun 13

KINGSEMI's (SHSE:688037) Problems Go Beyond Weak Profit

May 03

KINGSEMI (SHSE:688037) Is Doing The Right Things To Multiply Its Share Price

Apr 11

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

Mar 19

KINGSEMI Co., Ltd.'s (SHSE:688037) P/E Is Still On The Mark Following 26% Share Price Bounce

Mar 01

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥3.8B ) 688037 } overtreffen de korte termijn passiva ( CN¥1.4B ).

Langlopende schulden: De kortetermijnactiva 688037 ( CN¥3.8B ) overtreffen de langetermijnschulden ( CN¥1.1B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 1.3% ) 688037 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 688037 is de afgelopen 5 jaar gestegen van 0% naar 46.9%.

Schuldendekking: De schuld van 688037 wordt niet goed gedekt door de operationele kasstroom ( 18.2% ).

Rentedekking: De rentebetalingen op de schuld van 688037 worden goed gedekt door EBIT ( 11.2 x dekking).

KINGSEMI Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

KINGSEMI (SHSE:688037) Has A Somewhat Strained Balance Sheet

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 15%, revenue downgraded

KINGSEMI Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

KINGSEMI Co., Ltd. (SHSE:688037) Not Flying Under The Radar

New minor risk - Profit margin trend

KINGSEMI (SHSE:688037) Could Be Struggling To Allocate Capital

KINGSEMI (SHSE:688037) Has A Somewhat Strained Balance Sheet

Price target decreased by 12% to CN¥79.49

Price target decreased by 12% to CN¥79.49

Consensus EPS estimates fall by 14%

Investor sentiment deteriorates as stock falls 25%

KINGSEMI Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Earnings Tell The Story For KINGSEMI Co., Ltd. (SHSE:688037) As Its Stock Soars 27%

KINGSEMI Co., Ltd., Annual General Meeting, Jun 17, 2024

Price target decreased by 20% to CN¥130

KINGSEMI's (SHSE:688037) Problems Go Beyond Weak Profit

First quarter 2024 earnings: EPS and revenues miss analyst expectations

KINGSEMI (SHSE:688037) Is Doing The Right Things To Multiply Its Share Price

KINGSEMI Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Does KINGSEMI (SHSE:688037) Have A Healthy Balance Sheet?

KINGSEMI Co., Ltd.'s (SHSE:688037) P/E Is Still On The Mark Following 26% Share Price Bounce

Full year 2023 earnings: EPS and revenues miss analyst expectations

KINGSEMI Co., Ltd. (SHSE:688037) announces an Equity Buyback for CNY 20 million worth of its shares.

Investor sentiment deteriorates as stock falls 15%

KINGSEMI Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 13% to CN¥174

New major risk - Earnings quality

Investor sentiment deteriorates as stock falls 15%

KINGSEMI Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023

Price target increased by 8.4% to CN¥206

Price target increased by 8.6% to CN¥281

Price target increased by 7.5% to CN¥258

Price target increased by 7.9% to CN¥258

Consensus revenue estimates increase by 11%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased by 8.5% to CN¥240

Price target increased by 12% to CN¥221

Price target increased to CN¥205

Less than half of directors are independent

Price target increased to CN¥205

Consensus EPS estimates increase by 38%

Third quarter 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.21 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.33 in 2Q 2021)

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.16 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.09 loss in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.58 (vs CN¥0.46 in FY 2019)

New 90-day low: CN¥82.45

KINGSEMI Co., Ltd. to Report Fiscal Year 2020 Results on Mar 20, 2021

New 90-day low: CN¥85.44

New 90-day low: CN¥93.62

New 90-day low: CN¥99.98

KINGSEMI Co., Ltd. to Report First Half, 2020 Results on Aug 27, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven